6Auer J, Scheibner P, Misehe T, et al[ J ]. Am Heart J 2001 ; 142(5) :838 - 842. 被引量：1
二级参考文献21
1Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA,2004,291:228-238. 被引量：1
2Hollowell JG, Staehling NW, Flanders WD, et al. Serum thyrotropin,thyroxin and thyroid antibodies in the United States Population ( 1988 to 1994). National Health and Nutrition Examination Survey (NHANES Ⅲ). J Clin Endocrinol Metab,2002,87:489-499. 被引量：1
3Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch of Intern Med,2000,160:526-534. 被引量：1
4Laurery P, Bulow Pedersen I, Knudsen N, et al. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid,2001,1:457-469. 被引量：1
6Munte TF, Radamm C, Johannes S, et al. Alteration of cognitive function induced by exogenous application of thyroid hormones in healthy men: a double-blind cross-over study using event-related brain potential.Thyroid, 2001,11: 385-391. 被引量：1
7Parle JV, Maisonneuve P, Sheppard MC, et al. Prediction of all cause and cardiovascular mortality in elderly people from one low serum thyrothropin result: a 10 year cohort study. Lancet,2001,358:861-865. 被引量：1
8Auer J, Scheibner P, Mische T, et al. Subclinical hyperthroidism as a risk factor for atrial fibrillation. Am Heart J, 2001,142 : 835-842 . 被引量：1
9Sawin CT. Subclinical hyperthyroidism and atrial fibrillation. Thyroid,2002,12: 501-503. 被引量：1
10Biondi B, Palmieri EA, Fazio S, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in youngand middle-aged patients. J Clin Endocrinol Metab, 2000, 85:4701-4705. 被引量：1
1Hay ID, Bayer MF, Kaplan MM, et al. American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays The Committee on Nomenclature of the American Thyroid [J]. Clin Chem, 1991,37 (11): 2002-2008. 被引量：1
2Stockigt JR. Guidelines for diagnosis and monitoring of thyroid disease: nonthyroidal illness [J]. Clin Chem, 1996, 42(1): 188-192. 被引量：1
3Owen PJ, Lazarus JH. Subclinical hypothyroidism: the case for treatment [J]. Trends Endocrinol Metab, 2003, 14(16): 257-261. 被引量：1
4Tunbridge WM, Vanderpump MP. Population screening for autoimmune thyroid disease [J]. Endocrinol Metab Clin North Am, 2000, 29 (2): 239-253. 被引量：1
5Surks Mt, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management[J]. JAMA, 2004, 291(2): 228-238. 被引量：1
6Fatourechi V, Laukarani M, Schryver PG, et al. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L)[J]. Mayo Clin Proc, 2003, 78(5): 554-560. 被引量：1
7Jorde R, Waterloo K, Storhaug H, et al. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment[J]. J Clin Endocrinol Metab, 2006, 91(1): 145-153. 被引量：1
8Ahinova AE, Tortiner FB, Aktutik M, et al. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism [J]. Clin Endocrinol(Oxf), 2006, 65(4): 530-535. 被引量：1
9Barbe F, Klein M, Chango A, et al. Homocysteine, folate, vitamin B 12, and transeobalamins in pationts undergoing successive hypo- and hyperthyroid states [J]. J Clin Endocrinol Metab, 2001, 86(4): 1845-1846. 被引量：1
10Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis[J]. Circulation, 2003, 107(3): 398-404. 被引量：1
